New Focus of Enhancement – Malignant
HIDEInteractive Transcript
0:01
So our next case is a 61-year-old
0:03
woman for high-risk screening,
0:05
and she's a BRCA2 gene mutation carrier.
0:08
All right, so here's our BRCA2 gene mutation
0:11
carrier patient for high-risk screening.
0:14
On our left side, we have our STIR
0:16
image, and on the right, we have
0:17
a post-contrast subtracted image.
0:20
And just going through from
0:24
the top, of course, this patient had
0:28
comparison studies as well because
0:30
she's been having screening every year.
0:39
And what we noticed was this enhancing focus,
0:46
with kind of borderline focus
0:49
slash small mass because it was
0:51
close to 5 mm in size.
0:54
And when you look at the corresponding
0:55
image on the STIR, it's STIR hypointense,
0:59
there's nothing really there that we're seeing.
1:03
And it was new from previous, and if we go to one
1:09
on one layout and zoom in on this a little bit.
1:14
I think we can see that this is a little
1:18
bit more irregular in terms of its borders.
1:23
It's a little hard to see,
1:24
but it's not exactly a circumscribed
1:28
border as far as this focus goes.
1:30
So since this was new in a BRCA2 gene
1:34
mutation carrier, this was biopsied
1:36
and this turned out to be malignant.
1:38
So this was an invasive lobular carcinoma.
Lisa Ann Mullen, MD
Assistant Professor; Breast Imaging Fellowship Director
Johns Hopkins Medicine
© 2024 MRI Online. All Rights Reserved.